Upgrade to SI Premium - Free Trial

BMO Capital Downgrades Amgen (AMGN) to Market Perform

July 26, 2017 5:09 AM
BMO Capital downgraded Amgen (NASDAQ: AMGN) from Outperform to Market Perform with a price target of $199.00.Analyst Ian Somaiya called ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Downgrades Hot Comments Hot Downgrades

Next Articles